Nevertheless, silencing of PRSS1 has been reported to inhibit the extracellular signal-regulated kinase (ERK) signaling pathway by reducing PAR-2 activation, thereby suppressing the growth and proliferation of gastric carcinoma cells [69]. Here, PRSS1 is linked to gastric carcinoma.